First US patients in pulmonary artery denervation trial
Henry Ford Health has enrolled the first US patients in a global clinical trial evaluating pulmonary artery denervation for pulmonary hypertension related to heart disease. Henry Ford Health in Detroit has conducted the first procedures globally in a clinical trial evaluating pulmonary artery denervation, an investigational treatment for people with pulmonary hypertension related to heart disease. The minimally invasive procedures were conducted on August 21 at Henry Ford Hospital in Detroit, marking the enrollment of the first two patients in the PULSE-LHD study. This milestone represents a step in the investigation of a therapy designed to address a serious condition that can affect breathing, exercise capacity, and overall quality of life for patients with complex cardiovascular disease. Researchers hope the study will help determine whether the investigational approach could expand options for patients living with pulmonary hypertensive related to the heart disease and potentially lead to future treatment options for those with limited alternatives.
게시됨 : 3일 전 ~에 의해 ~에 Health Science
Henry Ford Health performed the first procedures globally in a clinical trial evaluating pulmonary artery denervation, an investigational treatment for people with pulmonary hypertension related to he... [4613 symbols]
